BI 860585
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 860585, covering 2019-01-04 to 2019-01-04. Get the full timeline:
Most recent: Clinical Trial Update: BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors [Phase 1]